HealthDay reports on a paper published in JAMA Internal Medicine: “The costly form of radiation therapy that has become the norm for prostate cancer in the United States may be no better than the older, cheaper variety — at least for some men, a new study suggests. Researchers found that among more than 1,000 U.S. [...]
The following is a guest post by Harold DeMonaco, MS, one of our expert reviewers on HealthNewsReview.org, and a frequent guest blogger on this site. ———————- The American Society of Clinical Oncology (ASCO) will hold its annual meeting starting on May 31st in Chicago, Illinois. While we have consistently cautioned against over reading the abstracts [...]
Women with breast cancer who are active on social media make a vital contribution to our public dialogue. So, when I read Angelina Jolie’s New York Times opinion piece, “My Medical Choice,” about her decision to have bilateral prophylactic mastectomy after breast cancer gene testing, I turned to some of the women I follow through [...]
That’s the way Barbara is described on the website of Breast Cancer Action, which she ran until 2010 when she stepped down because of her ALS diagnosis. She died last Friday. You can read more on their site. But I chose this key excerpt: “One of the most successful – and controversial – of the [...]
On Twitter, Liz Szabo of USA Today asks, “Is this the end of the PSA?” She was referring to new clinical guidelines released by the American Urological Association. She reported: “In a major break from the past, a leading medical group is advising men to think carefully before getting getting screened for prostate cancer. The [...]
The New York Times Sunday magazine piece, “Our Feel-Good War on Breast Cancer,” is by Peggy Orenstein who begins: “I used to believe that a mammogram saved my life. I even wrote that in the pages of this magazine. It was 1996, and I had just turned 35 when my doctor sent me for an [...]
Jim Thornton’s story is about prostate cancer screening. The six million dollar figure refers to the cost of screening for and treating prostate cancer. Excerpt: “At $1,000 or more per biopsy, the cost to U.S. health care for prostate biopsies alone is estimated to run into the billions each year. Whenever cancer is found, expenses [...]
That’s what journalist Seth Mnookin writes on Slate, stating, further, that it is “is wrong, grandiose, and cruel.” He writes, “I haven’t found a single cancer researcher who believes this means we’re on the verge of curing cancer.” And he reflects on some journalistic history in the same vein – from 1998: “…the New York [...]
The authors of the paper in JAMA Internal Medicine, “Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy,” wrote: Controversy exists about the frequency women should undergo screening mammography and whether screening interval should vary according to risk factors beyond age. And concluded, as a result of the analysis they report: Women [...]
I live in the Twin Cities, so I couldn’t avoid hearing about the University of Minnesota research paper in Nature this week, “APOBEC3B is an enzymatic source of mutation in breast cancer.” Had I lived anywhere else, I probably wouldn’t have heard anything about it. This laboratory finding was reported by the CBS TV station, [...]
Better than a competing piece by Reuters but still a little short on some details about this asthma drug study.
An adequate summary of this asthma drug trial’s design doesn’t make up for the overly optimistic tone about the drug’s future. A New York Times story was better.
This story focuses on a family that may have a rare genetic mutation that increases their risk of heart disease. Unfortunately, the “rare” part wasn’t mentioned until 1,600 words into this 2,100 word story.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2013 Health News Review
